SCHEMBL19783801

SCHEMBL19783801

COc1ccc(N)c(CCO)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.51
ALDH1A1 P00352 3/20 0.48
CYP3A4 P08684 1/20 0.48
ADRA1A P35348 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
THRB P10828 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
MCL1 Q07820 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
IDO1 P14902 2/20 0.43
AOC3 Q16853 1/20 0.42
HSD17B10 Q99714 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189619 1.00 CYP2D6 (0.51) CYP2D6ALDH1A1CYP3A4ADRA1ATAAR1
SCHEMBL5058376 0.88 ALDH1A1 (0.55) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL3579011 0.85 ALDH1A1 (0.52) CYP2D6ALDH1A1CYP3A4ADRA1ATAAR1
SCHEMBL3377786 0.85 ALDH1A1 (0.52) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL7701522 0.83 CYP2D6 (0.35) CYP2D6ADRA1ATAAR1MEN1KMT2A
SCHEMBL2019106 0.83 TAAR1 (0.68) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL22499932 0.82 MEN1 (0.53) ALDH1A1CYP3A4MEN1MAPTKMT2A
SCHEMBL27848999 0.81 ALDH1A1 (0.48) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL8680435 0.80 ALDH1A1 (0.47) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL1145887 0.79 ADRA1A (0.68) CYP2D6ADRA1ATAAR1IDO1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100432052-C Synthetic method for methoxy indole UNIV TIANJIN (CN) 2008-11-12 CN claimed
CN-1944405-A Synthetic method for methoxy indole UNIV TIANJIN (CN) 2007-04-11 CN claimed
US-12060347-B2 Bicyclic heteroaryl substituted compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-13 US disclosed
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
CN-112789259-A Method for repairing structure 昭和电工株式会社 2021-05-11 CN disclosed
CN-112752775-A Radical polymerizable resin composition and structural repair material 昭和电工株式会社 2021-05-04 CN disclosed
WO-2020203818-A1 ASBESTOS DETECTING AGENT, ASBESTOS DETECTING KIT, AND ASBESTOS DETECTING METHOD 広島県 2020-10-08 WO disclosed
EP-3484878-B1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2020-08-19 EP disclosed
WO-2020066364-A1 RADICAL POLYMERIZABLE RESIN COMPOSITION AND STRUCTURE REPAIRING MATERIAL 昭和電工株式会社 2020-04-02 WO disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
CN-109988093-A The aminated compounds for inhibiting SSAO/VAP-1 and its application in medicine 广东东阳光药业有限公司 2019-07-09 CN disclosed
CN-109689647-A The compound that bicyclic heteroaryl replaces 百时美施贵宝公司 2019-04-26 CN disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed
CN-100432052-C Synthetic method for methoxy indole UNIV TIANJIN (CN) 2008-11-12 CN disclosed
CN-1944405-A Synthetic method for methoxy indole UNIV TIANJIN (CN) 2007-04-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12060347-B2 Bicyclic heteroaryl substituted compounds F2, F2RL3, F12 CYP2D6 154/4885ALDH1A1 1598/4885CYP3A4 18/4885
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 CYP2D6 117/4885ALDH1A1 1618/4885CYP3A4 15/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 CYP2D6 154/4885ALDH1A1 1598/4885CYP3A4 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.